Fatal cases associated with pandemic influenza A (H1N1) reported in Greece. | Zendy

Maria Athanasiou | Zendy; Theodore Lytras | Zendy; G Spala | Zendy; Eleni Triantafyllou | Zendy; Kassiani Gkolfinopoulou | Zendy; Georgios Theocharopoulos | Zendy; Stavros Patrinos | Zendy; Kostas Danis | Zendy; Marios Detsis | Zendy; Sotirios Tsiodras | Zendy; Stefanos Bonovas | Zendy; Takis Panagiotopoulos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fatal cases associated with pandemic influenza A (H1N1) reported in Greece.

Author(s) -

Maria Athanasiou,

Theodore Lytras,

G Spala,

Eleni Triantafyllou,

Kassiani Gkolfinopoulou,

Georgios Theocharopoulos,

Stavros Patrinos,

Kostas Danis,

Marios Detsis,

Sotirios Tsiodras,

Stefanos Bonovas,

Takis Panagiotopoulos

Publication year - 2010

Publication title -

plos currents

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.282

H-Index - 49

ISSN - 2157-3999

DOI - 10.1371/currents.rrn1194

Subject(s) - medicine , pandemic , epidemiology , vaccination , covid-19 , immunosuppression , h1n1 influenza , epidemiological surveillance , disease , h1n1 pandemic , pediatrics , intensive care medicine , environmental health , immunology , infectious disease (medical specialty)

Between 18 May 2009 and 3 May 2010, a total of 149 fatal cases associated with pandemic influenza A (H1N1) were reported in Greece. Detailed case-based epidemiological information was available for the large majority of fatal cases. The time distribution follows an epidemic curve with a peak in the beginning of December 2009 and a second peak one month later. This is similar to that of laboratory confirmed cases and influenza-like illness cases from our sentinel surveillance system, with two weeks delay. The most commonly reported underlying conditions were chronic cardiovascular disease and immunosuppression, while the most frequently identified risk factor was obesity. These findings should be taken into consideration, when vaccination strategies are employed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research